Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours

by Mira M. Shenouda, Amy Gillgrass, Tina Nham, Richard Hogg, Amanda J. Lee, Marianne V. Chew, Mahsa Shafaei, Craig Aarts, Dean A. Lee, John Hassell, Anita Bane, Sukhbinder Dhesy-Thind, Ali A. Ashkar
Published 2017-07-01

EFFECTOR FUNCTIONS OF NATURAL KILLER CELL SUBSETS IN THE CONTROL OF HAEMATOLOGICAL MALIGNANCIES

by Angela eGismondi, Angela eGismondi, Helena eStabile, Paolo eNisti, Angela eSantoni, Angela eSantoni
Published 2015-11-01

Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles

by Kwang-Soo Kim, Dong-Hwan Kim, Dong-Hyun Kim
Published 2021-04-01

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies

by Yiting Wang, Yiting Wang, Hubing Shi, Huan Meng, Jie Xu
Published 2020-09-01

Adaptive NK Cell Therapy Modulated by Anti-PD-1 Antibody in Gastric Cancer Model

by Shahrokh Abdolahi, Zeinab Ghazvinian, Samad Muhammadnejad, Mohammad Ahmadvand, Mohammad Ahmadvand, Hamid Asadzadeh Aghdaei, Somayeh Ebrahimi-Barough, Jafar Ai, Mohammad Reza Zali, Javad Verdi, Kaveh Baghaei, Kaveh Baghaei
Published 2021-09-01

Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer

by Maxim Shevtsov, Maxim Shevtsov, Maxim Shevtsov, Maxim Shevtsov, Emil Pitkin, Alexander Ischenko, Stefan Stangl, William Khachatryan, Oleg Galibin, Stanley Edmond, Dominik Lobinger, Gabriele Multhoff
Published 2019-03-01

Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response

by Stephen Pierce, Eric S. Geanes, Todd Bradley, Todd Bradley, Todd Bradley
Published 2020-05-01

HSP70/IL-2 Treated NK Cells Effectively Cross the Blood Brain Barrier and Target Tumor Cells in a Rat Model of Induced Glioblastoma Multiforme (GBM)

by Farzaneh Sharifzad, Soura Mardpour, Saeid Mardpour, Esmaeil Fakharian, Adeleh Taghikhani, Amirhossein Sharifzad, Sahar Kiani, Yasaman Heydarian, Marek J Łos, Zahra Azizi, Saeid Ghavami, Amir Ali Hamidieh, Marzieh Ebrahimi
Published 2020-03-01

Cell‐based and antibody‐mediated immunotherapies directed against leukemic stem cells in acute myeloid leukemia: Perspectives and open issues

by Peter Valent, Karin Bauer, Irina Sadovnik, Dubravka Smiljkovic, Daniel Ivanov, Harald Herrmann, Yüksel Filik, Gregor Eisenwort, Wolfgang R. Sperr, Werner Rabitsch
Published 2020-11-01

Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy

by Kari A. Shaver, Tayler J. Croom-Perez, Alicja J. Copik
Published 2021-04-01

PD-L1 blockade enhances anti-tumor efficacy of NK cells

by Jeremiah L. Oyer, Sarah B. Gitto, Deborah A. Altomare, Alicja J. Copik
Published 2018-11-01